tiprankstipranks
Trending News
More News >
P3 Health Partners (PIII)
NASDAQ:PIII
US Market
Advertisement

P3 Health Partners (PIII) Earnings Dates, Call Summary & Reports

Compare
115 Followers

Earnings Data

Report Date
Mar 26, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
-7.54
Last Year’s EPS
-18
Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 13, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call highlighted several positive developments, including increased capitated revenue, successful operational improvements, strategic ventures, and reduced operating expenses. However, these are counterbalanced by significant adjusted EBITDA losses and revised financial guidance, indicating ongoing financial challenges.
Company Guidance
During P3 Health's Third Quarter 2025 Earnings Call, the company provided guidance on its financial performance and strategic initiatives. The call highlighted a 6% increase in capitated revenue and a significant $100 million year-over-year improvement in EBITDA, despite an adjusted EBITDA loss of $45.9 million for the quarter. P3 Health reported a normalized adjusted EBITDA loss of approximately $70 million year-to-date and revised its full-year adjusted EBITDA guidance to a range of minus $110 million to minus $95 million. The company is focusing on operational improvements, including a strategic joint venture to add 13,000 fully accretive ACO members and a pipeline of 25,000 Medicare Advantage lives for 2026. Medical margin for the quarter was reported at $4.4 million, or $13 PMPM, while operating expenses improved by $10.4 million, or 33%, compared to the previous year. The company is executing on an EBITDA expansion opportunity of $120 million to $170 million over the next five quarters, driven by factors such as improved provider alignment and clinical program scaling, with expectations for meaningful profitability in 2026.
Capitated Revenue Increase
Capitated revenue increased by roughly 6%, demonstrating the impact of clinical programs and utilization management efforts.
Operational Improvement Plan Success
Achieved over $100 million in EBITDA improvement year-over-year due to the embedded operational improvement plan.
Strategic Joint Venture
Moving forward with a joint venture that will add approximately 13,000 fully accretive ACO members, improving profitability and cash flow.
Provider Network Optimization
Rationalizing provider network to improve margin performance by exiting non-aligned groups and focusing on those where the Care Enablement Model delivers strong outcomes.
Tier 1 Provider Performance
Tier 1 providers performed 17.4% higher in closures compared to non-Tier 1 providers, demonstrating stronger documentation accuracy and quality performance.
Medical Margin Improvement
Medical margin for the quarter was $4.4 million or $13 PMPM compared to $500,000 or $1 PMPM in the prior period, indicating improvement.
Operating Expense Reduction
Operating expense for the quarter was reduced by $10.4 million or 33% compared to the prior year period.

P3 Health Partners (PIII) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

PIII Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 26, 2026
2025 (Q4)
-7.54 / -
-18
Nov 13, 2025
2025 (Q3)
-5.29 / -9.67
-15.537.61% (+5.83)
Aug 14, 2025
2025 (Q2)
-5.86 / -6.23
-7.516.93% (+1.27)
May 15, 2025
2025 (Q1)
-8.16 / -6.28
-821.50% (+1.72)
Mar 27, 2025
2024 (Q4)
-4.09 / -18.00
-11-63.64% (-7.00)
Nov 12, 2024
2024 (Q3)
-1.84 / -15.50
-6-158.33% (-9.50)
Aug 07, 2024
2024 (Q2)
-2.20 / -7.50
-4.5-66.67% (-3.00)
May 08, 2024
2024 (Q1)
-6.36 / -8.00
-1127.27% (+3.00)
Mar 28, 2024
2023 (Q4)
-5.48 / -11.00
-11390.27% (+102.00)
Nov 08, 2023
2023 (Q3)
-8.97 / -6.00
-13.555.56% (+7.50)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

PIII Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 13, 2025
$7.00$6.84-2.29%
Aug 14, 2025
$6.94$6.78-2.31%
May 15, 2025
$8.30$7.99-3.73%
Mar 27, 2025
$9.04$8.62-4.65%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does P3 Health Partners (PIII) report earnings?
P3 Health Partners (PIII) is schdueled to report earning on Mar 26, 2026, After Close (Confirmed).
    What is P3 Health Partners (PIII) earnings time?
    P3 Health Partners (PIII) earnings time is at Mar 26, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is PIII EPS forecast?
          PIII EPS forecast for the fiscal quarter 2025 (Q4) is -7.54.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis